PL2459203T3 - Bakterie kwasu mlekowego i bifidobakterie do leczenia endotoksemii - Google Patents

Bakterie kwasu mlekowego i bifidobakterie do leczenia endotoksemii

Info

Publication number
PL2459203T3
PL2459203T3 PL10747076T PL10747076T PL2459203T3 PL 2459203 T3 PL2459203 T3 PL 2459203T3 PL 10747076 T PL10747076 T PL 10747076T PL 10747076 T PL10747076 T PL 10747076T PL 2459203 T3 PL2459203 T3 PL 2459203T3
Authority
PL
Poland
Prior art keywords
bifidobacteria
lactic acid
acid bacteria
treating endotoxemia
endotoxemia
Prior art date
Application number
PL10747076T
Other languages
English (en)
Inventor
Rémy BURCELIN
Didier Carcano
Pierre Desreumaux
Sampo Lahtinen
Nina Rautonen
Heli Putaala
Kirsti Tiihonen
Rodolphe Barrangou
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Publication of PL2459203T3 publication Critical patent/PL2459203T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL10747076T 2009-07-30 2010-07-30 Bakterie kwasu mlekowego i bifidobakterie do leczenia endotoksemii PL2459203T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US22998009P 2009-07-30 2009-07-30
US31240010P 2010-03-10 2010-03-10
US32194910P 2010-04-08 2010-04-08
US32591910P 2010-04-20 2010-04-20
PCT/IB2010/053482 WO2011013106A1 (en) 2009-07-30 2010-07-30 Lactic acid bacteria and bifidobacteria for treating endotoxemia
EP10747076.7A EP2459203B1 (en) 2009-07-30 2010-07-30 Lactic acid bacteria and bifidobacteria for treating endotoxemia

Publications (1)

Publication Number Publication Date
PL2459203T3 true PL2459203T3 (pl) 2019-04-30

Family

ID=43125561

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10747076T PL2459203T3 (pl) 2009-07-30 2010-07-30 Bakterie kwasu mlekowego i bifidobakterie do leczenia endotoksemii

Country Status (8)

Country Link
US (2) US9259447B2 (pl)
EP (1) EP2459203B1 (pl)
CN (1) CN102470152A (pl)
BR (1) BR112012001812B1 (pl)
DK (1) DK2459203T3 (pl)
ES (1) ES2708450T3 (pl)
PL (1) PL2459203T3 (pl)
WO (1) WO2011013106A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
PH12013501382A1 (en) 2010-12-31 2013-09-02 Abbott Lab0Ratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
CN107595860A (zh) 2011-07-22 2018-01-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
EP2750523A1 (en) 2011-08-29 2014-07-09 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
FI20116008A0 (fi) * 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
CN102792919B (zh) * 2012-08-08 2015-09-09 上海交通大学 悉生动物肥胖模型的构建方法及其应用
JP6637885B2 (ja) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
AU2015284425B2 (en) 2014-07-01 2021-04-01 Probi USA, Inc. Bi-layer dual release probiotic tablets
SG11201703395PA (en) 2014-10-31 2017-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN105456563A (zh) * 2015-12-25 2016-04-06 天津天狮生物发展有限公司 一种改善肠道功能的组合物
JP7111699B2 (ja) * 2016-09-16 2022-08-02 デュポン ニュートリション バイオサイエンシーズ エーピーエス 細菌
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CN107787916A (zh) * 2017-10-28 2018-03-13 蚌埠宏瑞园林有限公司 一种预防雏鸭传染性浆膜炎的养殖方法
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
CN111514129A (zh) * 2020-05-14 2020-08-11 南开大学 Egcg在制备改善或治疗内源性内毒素血症药物或保健食品中的应用
BE1028802B1 (fr) * 2020-11-16 2022-06-14 Le Centre Wallon De Rech Agronomiques Développement d'une composition symbiotique comme un additif d'alimentation pour les porcelets ou les truies gestantes pour moduler le microbiote intestinal des porcelets au temps du sevrage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
US20040047868A1 (en) * 2000-07-03 2004-03-11 Gerald Pang Treating endotoxemia and related disorders with probiotics
ES2292744T3 (es) * 2001-02-06 2008-03-16 Societe Des Produits Nestle S.A. Union de endotoxinas por bacterias y bifidobacterias del acido lactico.
US20040096427A1 (en) * 2001-05-03 2004-05-20 Pinaki Panigrahi Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal dysfunctions including inflammation in the gastro-intestinal tract, neonatal necrotizing enterocolitis (nec) and bacterial sepsis
US6942857B2 (en) * 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
JPWO2008143182A1 (ja) 2007-05-17 2010-08-05 株式会社カネカ 甘草ポリフェノールを含有する組成物
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
AU2008333718B2 (en) * 2007-12-06 2012-03-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage

Also Published As

Publication number Publication date
BR112012001812A2 (pt) 2016-03-15
EP2459203B1 (en) 2018-10-31
US20160113976A1 (en) 2016-04-28
DK2459203T3 (en) 2019-02-18
EP2459203A1 (en) 2012-06-06
ES2708450T3 (es) 2019-04-09
WO2011013106A1 (en) 2011-02-03
CN102470152A (zh) 2012-05-23
US20120183516A1 (en) 2012-07-19
BR112012001812B1 (pt) 2019-04-16
US9259447B2 (en) 2016-02-16
US10543239B2 (en) 2020-01-28

Similar Documents

Publication Publication Date Title
PL2459203T3 (pl) Bakterie kwasu mlekowego i bifidobakterie do leczenia endotoksemii
PL3181134T3 (pl) Bifidobakterie do leczenia cukrzycy i stanów pokrewnych
PL2429305T3 (pl) Produkt mleczny i sposób
EP2136824A4 (en) USE OF SELECTED MILKY ACID BACTERIA TO REDUCE ATHEROSCLEROSIS
ZA201201389B (en) Sterilization method and appartus
EP2148577A4 (en) DAIRY PRODUCT AND PROCESS
GB0819604D0 (en) Milking apparatus and process
EP2476314A4 (en) DISINFECTANT COMPOSITION AND DISINFECTION PROCEDURE
ZA201001030B (en) Dairy product and process
PL2391391T3 (pl) Sposób sterylizacji
EP2338979A4 (en) BACTERIA CAPABLE OF PRODUCING LACTIC ACID AND METHOD FOR PRODUCING LACTIC ACID
IL217744A0 (en) Folate-targeted diagnostics and treatment
PL2630265T3 (pl) Szczepy bakterii kwasu mlekowego nadające teksturę
PL2496241T3 (pl) Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie
GB0913395D0 (en) Hygenic door handle system and method
GB0915491D0 (en) Electromagnetic tomography apparatuses and methods
PT2306973T (pt) Supositório vaginal que compreende ácido láctico
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
EP2301894A4 (en) STERILIZATION PROCESS AND STERILIZATION DEVICE
EP2146585A4 (en) DAIRY PRODUCT AND WHOLESALE EXPERIENCES
ZA201302018B (en) Product including lactic acid bacteria and a desiccant
PL3456334T3 (pl) Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków
GB201010717D0 (en) Disinfecting and sterilising solutions
ZA201008282B (en) Systems and methods for producing reduced cholesterol dairy products
EP2470286A4 (en) AIR CLEANING FILTER WITH GIMCHI MILKY ACID BACTERIA AND DISINFECTANTS AND METHOD FOR THE PRODUCTION THEREOF